Internal Medicine, Hematology & Oncology · New York, NY
NPI
1942641097
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
215 E 95th St Frnt 2
New York, NY, 10128
Phone (718) 732-4049
Groups this clinician bills Medicare through
Medicare paid, 2024
$266K
25,802 services
Medicare patients, 2024
197
Average age 71
Drug cost, 2024
$6.4M
1,401 prescriptions
Company payments, 2025
$9,186
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jean G Bustamante was code 88185 (surgical pathology examination), 667 times for 29 patients. In total Jean G Bustamante billed 25,802 services in 116 codes, and Medicare paid $266K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88185 Surgical Pathology Examination | Office | 667 | 29 | $22.56 | $15K |
| 36415 Venipuncture Blood Collection | Office | 556 | 172 | $8.61 | $4,787 |
| 85025 Blood Count | Office | 555 | 176 | $7.54 | $4,186 |
| 80053 Clinical Chemistry | Office | 365 | 152 | $10.26 | $3,747 |
| 99214 Office E&M - Established | Office | 307 | 148 | $106.32 | $33K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 232 | 60 | $52.27 | $12K |
| 82784 Immunoassay | Office | 225 | 51 | $9.02 | $2,030 |
| 83540 Clinical Chemistry | Office | 197 | 108 | $6.34 | $1,249 |
| 82728 Clinical Chemistry | Office | 196 | 108 | $13.36 | $2,619 |
| 83550 Clinical Chemistry | Office | 196 | 109 | $8.57 | $1,680 |
| 83615 Clinical Chemistry | Office | 144 | 79 | $5.92 | $852 |
| 83521 Immunoassay | Office | 140 | 50 | $16.68 | $2,336 |
| 82607 Clinical Chemistry | Office | 113 | 76 | $14.78 | $1,670 |
| 85044 Blood Count | Office | 96 | 71 | $4.22 | $405 |
| 84100 Clinical Chemistry | Office | 86 | 36 | $4.65 | $400 |
By year: 2022 $35K for 371 services; 2023 $151K for 12,016 services; 2024 $266K for 25,802 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 667 | 29 | $22.56 | $15K |
| 36415 Venipuncture Blood Collection | 556 | 172 | $8.61 | $4,787 |
| 85025 Blood Count | 555 | 176 | $7.54 | $4,186 |
| 80053 Clinical Chemistry | 365 | 152 | $10.26 | $3,747 |
| 82784 Immunoassay | 225 | 51 | $9.02 | $2,030 |
| 83540 Clinical Chemistry | 197 | 108 | $6.34 | $1,249 |
| 83550 Clinical Chemistry | 196 | 109 | $8.57 | $1,680 |
| 82728 Clinical Chemistry | 196 | 108 | $13.36 | $2,619 |
| 83615 Clinical Chemistry | 144 | 79 | $5.92 | $852 |
| 83521 Immunoassay | 140 | 50 | $16.68 | $2,336 |
Medicare prescription drug claims, 2024
In 2024, the drug Jean G Bustamante prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 173 prescriptions and refills. In total Jean G Bustamante wrote 1,401 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Procrit Epoetin Alfa | 173 | 173 | 28 | $316K |
| Aranesp Darbepoetin Alfa In Polysorbat | 113 | 113 | 22 | $291K |
| Eliquis Apixaban | 82 | 126 | 23 | $71K |
| Anastrozole Generic | 68 | 170 | 28 | $800 |
| Abiraterone Acetate Generic | 55 | 55 | Under 11 | $250K |
| Hydroxyurea Generic | 52 | 121 | 18 | $1,193 |
| Xarelto Rivaroxaban | 46 | 76 | 11 | $41K |
| Somatuline Depot Lanreotide Acetate | 37 | 37 | Under 11 | $329K |
| Prednisone Generic | 36 | 58 | 12 | $337 |
| Akynzeo Fosnetupitant/Palonosetron | 36 | 36 | Under 11 | $39K |
| Dexamethasone Generic | 34 | 56 | 12 | $836 |
| Imbruvica Ibrutinib | 29 | 33 | Under 11 | $526K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 29 | 29 | Under 11 | $514K |
| Ibrance Palbociclib | 28 | 33 | Under 11 | $549K |
| Lupron Depot Leuprolide Acetate | 26 | 77 | Under 11 | $153K |
Brand drugs: 883 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jean G Bustamante $9,186 ($6,851 in general payments such as food, travel and fees and $2,335 for research) from 8 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $4,041.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.